136 related articles for article (PubMed ID: 30301934)
1. Tumor DNA-dependent protein kinase catalytic subunit expression is associated with hepatitis B surface antigen status and tumor progression in patients with hepatocellular carcinoma.
Shimizu T; Aoki T; Mori S; Iso Y; Kato M; Ishizuka M; Kubota K
Sci Rep; 2018 Oct; 8(1):15019. PubMed ID: 30301934
[TBL] [Abstract][Full Text] [Related]
2. Promyelocytic leukaemia protein links DNA damage response and repair to hepatitis B virus-related hepatocarcinogenesis.
Chung YL; Wu ML
J Pathol; 2013 Aug; 230(4):377-87. PubMed ID: 23620081
[TBL] [Abstract][Full Text] [Related]
3. DNA-PKcs: A promising therapeutic target in human hepatocellular carcinoma?
Pascale RM; Joseph C; Latte G; Evert M; Feo F; Calvisi DF
DNA Repair (Amst); 2016 Nov; 47():12-20. PubMed ID: 27789167
[TBL] [Abstract][Full Text] [Related]
4. Correlation of clinical characteristics with detection of hepatitis B virus X gene in liver tissue in HBsAg-negative, and HCV-negative hepatocellular carcinoma patients.
Higashi Y; Tada S; Miyase S; Hirota K; Imamura H; Kamio T; Suko H
Liver; 2002 Oct; 22(5):374-9. PubMed ID: 12390472
[TBL] [Abstract][Full Text] [Related]
5. Linc00152 promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma.
Deng X; Zhao XF; Liang XQ; Chen R; Pan YF; Liang J
Biomed Pharmacother; 2017 Jun; 90():100-108. PubMed ID: 28343069
[TBL] [Abstract][Full Text] [Related]
6. Deregulation of DNA-dependent protein kinase catalytic subunit contributes to human hepatocarcinogenesis development and has a putative prognostic value.
Evert M; Frau M; Tomasi ML; Latte G; Simile MM; Seddaiu MA; Zimmermann A; Ladu S; Staniscia T; Brozzetti S; Solinas G; Dombrowski F; Feo F; Pascale RM; Calvisi DF
Br J Cancer; 2013 Nov; 109(10):2654-64. PubMed ID: 24136149
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of proliferating cell nuclear antigen expression in hepatocellular carcinoma.
Ng IO; Lai EC; Fan ST; Ng M; Chan AS; So MK
Cancer; 1994 May; 73(9):2268-74. PubMed ID: 7513246
[TBL] [Abstract][Full Text] [Related]
8. Significance of hepatitis B virus surface antigen, hepatitis C virus expression in hepatocellular carcinoma and pericarcinomatous tissues.
Xuan SY; Xin YN; Chen H; Shi GJ; Guan HS; Li Y
World J Gastroenterol; 2007 Mar; 13(12):1870-4. PubMed ID: 17465484
[TBL] [Abstract][Full Text] [Related]
9. SiRNA-targeted carboxypeptidase D inhibits hepatocellular carcinoma growth.
Jin T; Fu J; Feng XJ; Wang SM; Huang X; Zhu MH; Zhang SH
Cell Biol Int; 2013 Sep; 37(9):929-39. PubMed ID: 23589395
[TBL] [Abstract][Full Text] [Related]
10. The mitochondrial hinge protein, UQCRH, is a novel prognostic factor for hepatocellular carcinoma.
Park ER; Kim SB; Lee JS; Kim YH; Lee DH; Cho EH; Park SH; Han CJ; Kim BY; Choi DW; Yoo YD; Yu A; Lee JW; Jang JJ; Park YN; Suh KS; Lee KH
Cancer Med; 2017 Apr; 6(4):749-760. PubMed ID: 28332314
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA‑1271‑5p alleviates the malignant development of hepatitis B virus‑mediated liver cancer via binding to AQP5.
Li Z; Ma L; Di L; Lin X
Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33760167
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis B virus infection is associated with younger median age at diagnosis and death in cancers.
Wei XL; Luo HY; Li CF; Jin Y; Zeng ZL; Ju HQ; Wu QN; Wang Y; Mao MJ; Liu WL; Jia WH; Zhang HZ; Li YH; Wang F; Xu RH
Int J Cancer; 2017 Jul; 141(1):152-159. PubMed ID: 28369849
[TBL] [Abstract][Full Text] [Related]
13. High alpha-fetoprotein level correlates with high stage, early recurrence and poor prognosis of hepatocellular carcinoma: significance of hepatitis virus infection, age, p53 and beta-catenin mutations.
Peng SY; Chen WJ; Lai PL; Jeng YM; Sheu JC; Hsu HC
Int J Cancer; 2004 Oct; 112(1):44-50. PubMed ID: 15305374
[TBL] [Abstract][Full Text] [Related]
14. Intrahepatic distribution of hepatitis B virus antigens in patients with and without hepatocellular carcinoma.
Safaie P; Poongkunran M; Kuang PP; Javaid A; Jacobs C; Pohlmann R; Nasser I; Lau DT
World J Gastroenterol; 2016 Mar; 22(12):3404-11. PubMed ID: 27022222
[TBL] [Abstract][Full Text] [Related]
15. [Expression of CAS in hepatocellular carcinoma tissues and its relationship with HBV infection].
Zang H; Zhao JM; Ji D; Sun YL; Zhou GD; Zhao YL; Chen GF
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2012 Aug; 26(4):285-7. PubMed ID: 23189846
[TBL] [Abstract][Full Text] [Related]
16. Predictive value of expression and promoter hypermethylation of XAF1 in hepatitis B virus-associated hepatocellular carcinoma treated with transplantation.
Zhang F; Wu LM; Zhou L; Chen QX; Xie HY; Feng XW; Zheng SS
Ann Surg Oncol; 2008 Dec; 15(12):3494-502. PubMed ID: 18830757
[TBL] [Abstract][Full Text] [Related]
17. [Seroconversion of HBs antigen to anti-HBs].
Ohkoshi S
Nihon Rinsho; 2004 Aug; 62 Suppl 8():88-92. PubMed ID: 15453293
[No Abstract] [Full Text] [Related]
18. miR-106b promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma.
Yen CS; Su ZR; Lee YP; Liu IT; Yen CJ
World J Gastroenterol; 2016 Jun; 22(22):5183-92. PubMed ID: 27298561
[TBL] [Abstract][Full Text] [Related]
19. Differential DNA methylation associated with hepatitis B virus infection in hepatocellular carcinoma.
Su PF; Lee TC; Lin PJ; Lee PH; Jeng YM; Chen CH; Liang JD; Chiou LL; Huang GT; Lee HS
Int J Cancer; 2007 Sep; 121(6):1257-64. PubMed ID: 17534893
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis B virus (HBV) DNA integration in patients with occult HBV infection and hepatocellular carcinoma.
Saitta C; Tripodi G; Barbera A; Bertuccio A; Smedile A; Ciancio A; Raffa G; Sangiovanni A; Navarra G; Raimondo G; Pollicino T
Liver Int; 2015 Oct; 35(10):2311-7. PubMed ID: 25677098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
